Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference — Neutral
OM GlobeNewsWire — June 05, 2025SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 46th annual Healthcare conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time.

SAN MATEO, Calif. , June 5, 2025 /PRNewswire/ -- Today, GoPro, Inc. (NASDAQ: GPRO) is pleased to announce the appointment of Mike Dennison to GoPro's Board of Directors.

TJ Maxx and Ilona Maher Team Up to Launch "You Sponsored by TJ Maxx": A First-of-its-Kind Initiative to Sponsor True Original Women — Neutral
TJX PRNewsWire — June 05, 2025Alongside powerhouse Co-Sponsors Jen Atkin, Carly Cushnie, Renée Elise Goldsberry, Chloe Flower and Ilona Maher, TJ Maxx aims to unlock new opportunities and help open doors for 10 deserving women FRAMINGHAM, Mass. , June 5, 2025 /PRNewswire/ -- Today, TJ Maxx (NYSE: TJX) is taking center stage as the official sponsor of True Originals—women who are boldly and authentically themselves—with the launch of You Sponsored by TJ Maxx , a groundbreaking new program that brings dynamic sponsorships to everyday women for being exactly who they already are.

Eversource Benefits From Strategic Investments & Renewable Focus — Positive
ES Zacks Investment Research — June 05, 2025ES targets $24.2 billion in capital upgrades by 2029, boosting grid reliability and advancing New England's clean energy shift.

ExxonMobil Consortium Reports $10.4B Profit From Guyana in 2024 — Neutral
XOM Zacks Investment Research — June 05, 2025XOM and partners raked in $10.4B from Guyana in 2024 as output rose and the basin tightened under their control.

BP Secures Long-Term LNG Deal With India's Torrent Power — Positive
BP Zacks Investment Research — June 05, 2025BP signs decade-long LNG deal with Torrent Power to fuel India's gas plants and distribution push.

Jack Daniel's maker Brown-Forman forecasts annual revenue, profit drop on tariff woes — Negative
BF-A BF-B Reuters — June 05, 2025Brown-Forman forecast a decline in annual revenue and profit on Thursday, as the Jack Daniel's maker navigates soft consumer spending amid tariff-related uncertainties, sending its shares down about 14% in premarket trading.

Foremost Clean Energy Announces 3-Year Exploration Drill Permit for Murphy Lake South Uranium Property; Targeting Summer Drill Program — Neutral
FMST GlobeNewsWire — June 05, 2025Highlights include: Murphy Lake South (17,676 acres) is strategically located adjacent to the LaRocque Lake Conductive Corridor—host to IsoEnergy's high-grade Hurricane Deposit Previous drilling by Denison Mines has identified anomalous uranium and pathfinder elements, highlighting the potential for a meaningful new discovery. Exploration permit covers ground geophysics, surface sampling, and up to 30 drill holes VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM — Neutral
TEM Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Tempus AI, Inc.("Tempus" or the "Company") (NASDAQ:TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRA — Neutral
SVRA Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Savara Inc.("Savara" or the "Company") (NASDAQ:SVRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR — Neutral
SMLR Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ:SMLR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE — Neutral
NPCE Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:NPCE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

TAMPA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced that options on its common stock are approved for trading on the Nasdaq Options Market.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADTRAN Holdings, Inc. - ADTN — Neutral
ADTN Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc.("ADTRAN" or the "Company") (NASDAQ:ADTN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules — Neutral
CLRB GlobeNewsWire — June 05, 2025FLORHAM PARK, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the entry into definitive agreements to raise $2.5 million from the sale of shares of the company's common stock priced at-market for Nasdaq purposes. The closing of the offering is expected to occur on or about June 6, 2025, subject to satisfaction of customary closing conditions.

Precision Optics Expands Facilities to Meet Growing Backlog — Neutral
POCI GlobeNewsWire — June 05, 2025Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. and LITTLETON, Mass.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in UroGen Pharma Ltd. of Class Action Lawsuit And Upcoming Deadlines - URGN — Neutral
URGN Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. ("UroGen" or the "Company") (NASDAQ:URGN).

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apple Inc. - AAPL — Neutral
AAPL Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Apple Inc.("Apple" or the "Company") (NASDAQ:AAPL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT — Neutral
FLGT Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ:FLGT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meta Platforms, Inc. - META — Neutral
META Accesswire — June 05, 2025NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Meta Platforms, Inc.("Meta" or the "Company") (NASDAQ:META). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
